Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -360,395 | -89,225 | -106,014 | -57,649 | -43,515 |
| Depreciation Amortization | 11,926 | 10,229 | 9,035 | 5,125 | 4,941 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 10,742 |
| Accounts receivable | -35,689 | -4,144 | 1,364 | 1,982 | 2,594 |
| Accounts payable and accrued liabilities | 8,840 | 1,832 | -1,736 | -3,512 | -3,177 |
| Other Working Capital | -29,401 | -8,118 | -8,965 | -55,928 | -79,560 |
| Other Operating Activity | 239,078 | 20,769 | -9,293 | 22,914 | 23,634 |
| Operating Cash Flow | $-165,641 | $-68,657 | $-115,609 | $-87,068 | $-84,341 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -514,853 | -126,499 | 11,884 | 83,250 | 22,570 |
| PPE Investments | -8,961 | -4,006 | -8,348 | -1,291 | -4,732 |
| Net Acquisitions | -25,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -162 | 0 | 0 |
| Investing Cash Flow | $-548,814 | $-130,505 | $3,374 | $81,959 | $17,838 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 752,457 | 202,315 | 93,771 | 738 | 3,663 |
| Common Stock Repurchased | -15,992 | -1,389 | -359 | 0 | N/A |
| Financing Cash Flow | $736,465 | $200,926 | $93,412 | $738 | $3,663 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -29 |
| Beginning Cash Position | 53,169 | 51,405 | 70,228 | 74,599 | 137,468 |
| End Cash Position | 75,179 | 53,169 | 51,405 | 70,228 | 74,599 |
| Net Cash Flow | $22,010 | $1,764 | $-18,823 | $-4,371 | $-62,869 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165,641 | -68,657 | -115,609 | -87,068 | -84,341 |
| Capital Expenditure | -8,961 | -4,006 | -8,348 | -1,291 | -4,732 |
| Free Cash Flow | -174,602 | -72,663 | -123,957 | -88,359 | -89,073 |